Api industry in india. India is self-sufficient in .

Api industry in india. There are 500 API manufacturers contributing about 8% in the global API Industry. However, despite being one of the top producers of medicines, India is highly dependent on China for APIs that are essential in the manufacturing of medicines. Pharma API Manufacturers in India – The Indian pharmaceutical industry stands in the top five positions based on volume and value. Mar 31, 2023 · The Indian active pharmaceutical ingredients industry will grow at a compound annual growth rate (CAGR) of 7-8% over the next 3-4 years, thanks to demand for formulations, global contract manufacturing opportunities, global customers looking to diversify their supply chain dependence from China to alternative destinations and Production Linked Scheme (PLI) incentives offered by the Government Apr 25, 2024 · With its name in the Forbes’ 2016 list of ‘India’s Super 50 Companies 2016’, Alembic Pharmaceuticals is one of the most popular pharmaceutical brands in India. India is a global hub for API manufacturing with a significant share of the global API The oncology segment in India's API industry is projected to grow significantly due to the increasing number of cancer cases. Aug 12, 2024 · Indian API industry players faced considerable volatility in earnings over FY2021-FY2023 on account of multiple headwinds such as rising raw material costs due to elevated crude oil prices and effective API production capabilities. Reviving India’s API industry. Mar 25, 2020 · India’s pharmaceutical market in 2018–2019 totaled $40 billion (both domestic and export use), according to the Pharmaceuticals Export Council of India, the authorized agency of the government of India for promotion of pharmaceutical exports from India and supported by India’s Ministry of Commerce and Industry. With the manufacturing of over 500 different APIs, India contributes 57 percent of APIs to the prequalified list of the World Health Organization (WHO). 31% during the forecast period (2024-2029). India is the largest supplier of generic medicines. The Indian API industry has evolved from being recognized as an industry manufacturing simple ‘API molecule’, to becoming the preferred destination for manufacturing the high QUICK LINKS. 12% year-on-year growth. Nov 21, 2019 · Today India is the fastest growing generic API producer for merchant market having grown from USD 2. India's API Export Landscape. 57% CAGR over next 5 years to Rs. Dependence on China for imports of APIs for certain essential medicines remains as high as 80-100%. ♦ PLI focuses on select molecules such as Penicillin G and 7-ACA Feb 22, 2024 · India's pharmaceutical industry is set to grow to $65 billion by 2024, with the API sector having a 35% share. 7 India API Testing Market Revenues & Volume Share, By Vertical, 2023 These countries are Brazil, China, Egypt, India, Jordan, Pakistan, South Africa, Thailand, Turkey, and Vietnam. The Indian pharmaceutical industry is the world’s third largest in terms of volume and thirteenth largest in terms of value. Dec 9, 2022 · India’s API industry is estimated at Rs. India is a global hub for API manufacturing with a significant share of the global API market. With around 1,500 units, India's API industry is highly fragmented. 14 Indian API suppliers also have a strong market position in all major markets. *Definition: The India Active Pharmaceutical Ingredients (API) Market refers to the sector within the pharmaceutical industry in India that focuses on the production, supply, and distribution of active pharmaceutical ingredients. Jan 23, 2023 · The Indian API market is anticipated to increase at a CAGR of 13. TIFAC is a {hink lank within governmen± setup which looks up to technologies on the horizon, assesses the lechnology trajectories and supports technology innovation in select areas of na±ional importance. India's pharmaceutical industry is set to soar to USD 65 (DST) , Government of India was established in 1988. India is one of the global leaders in the pharma industry and is a leading supplier of generic medicines and vaccines in the world. 90 billion by 2029. Post pandemic, there was a clear clamour for reshoring in the US. h\ ,qwhuphgldwhv . The report covers the India Active Pharmaceutical Ingredients (API) Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The sales of finished APIs are increasing at faster rate up to 40-45 per cent per year. India has a rapidly growing pharmaceutical industry and is becoming a major player in the global market. As the industry navigates regulatory complexities and embraces Aug 5, 2023 · Mansukh Mandaviya said that the 2017 border standoff with China at Doklam triggered India to rethink its self-reliant strategy regarding active pharma components as it was dependent on just one country for the import of 95 per cent of APIs for the formulation industry. 3746 Billion (Figure 1). Feb 15, 2024 · India's API intermediate industry is poised for significant growth in the coming years, fuelled by several factors. Specializing in range of API-related fields, TAPI works in areas such as chemical synthesis, fermentation, chromatography and plant extraction and now has the industry’s largest portfolio of over 300 API products. India's API exports have witnessed a remarkable growth trajectory over the past decade. 5% in the same period. com), Market size of active pharmaceutical ingredient (API) industry in India from 2016 to 2019 with estimates until 2024 (in billion Indian Nov 1, 2024 · Indian API Industry: Market Insights. API Manufacturer. Ltd. API - Commercial; API - Under Development; Intermediates; Certifications; Business Enquiry; Environment; WELCOME. India’s well-developed stronghold in generic process engineering would ensure that cost efficiency is achieved, however, fast-track of new plant setup is required if India must free itself of Chinese dominance in APIs 1,500 units, India's API industry is highly fragmented. Astoundingly, projections indicate a surge to US$ 18. TIFAC TECHNOLOGY INFORMATION, FORECASTING & ASSESSMENT COUNCIL (TIFAC) Jul 16, 2020 · The study recommended that to revive the API industry, in the immediate term there is a need for faster environment clearance, encouraging manufacturing of key APIs/intermediates and fermentation Aug 13, 2024 · ♦ API industry in India has estimated size of $13-$14 bn in 2023 . The Indian API Industry market is estimated to witness a high CAGR during the forecast period (2020-2026). 131,000 crore by 2026. From the viewpoint of the COVID-19 outbreak. May 3, 2021 · Background: Active Pharmaceutical Ingredient (API) manufacturing is an important segment of the Indian pharma industry. 7 per cent during the first four years – about 8 per cent higher than the generic API industry. Positioned as the world's third-largest API producer, India supplies 57% of APIs listed on the WHO prequalified catalogue, showcasing its pivotal role in the global pharmaceutical market, according to the report. Apr 28, 2023 · CDSCO regulates the manufacturing and import of API drugs in India. India API Market Size & Trends. Discover the top 10 pharma API manufacturers in India, leading the market with high-quality and innovative pharmaceutical ingredients for global healthcare. 14, 2020 (GLOBE NEWSWIRE) -- According to Global Market Estimates, the Indian API Market will grow rapidly at a CAGR of 8. With the increasing demand for generic drugs, the scope for API manufacturing in India is expected to continue to grow in the coming years. 4 India API Testing Market - Porter's Five Forces. 4%) over FY2021. 2 billion), accounting for a significant share of the global API market. The report also forecasts the India Active Pharmaceutical Ingredients (API) Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Invest India website, Indian API Industry – Reaching the full potential, KPMG in India, CII report, April 2020, Department of Commerce, Government of India The recent policy changes and government reforms in the space have positioned India as a preferred market for global investments and establishing local manufacturing facilities. Executive summary (1/2) In the context of the recent coronavirus outbreak, PwC has undertaken an independent study to understand the challenges faced by the Indian active pharmaceutical ingredient (API) industry and interventions required to revive the industry. 38 Billion in 2023 . Though the opportunity in the API industry has been utilised, there is a larger Jun 17, 2024 · Confederation of Indian Industry & Website (megagadget. So, if any manufacturer or importer plans to work with API drugs, they must understand the rules and regulations they must follow. ♦ The country witnessed favourable traction in PLI scheme for drugs industry . Chinese API industry will grow by just 6. 59 billion in 2022. Mumbai, 16 July 2020: PwC today launched a study "Reviving India's API industry" to understand the challenges faced by the Indian active pharmaceutical ingredient (API) industry and interventions required to revive the industry. APIs are the biologically active components of medications that are responsible for the intended therapeutic effects. Feb 15, 2024 · India Active Pharmaceutical Ingredients (API) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - The India Active Pharmaceutical Ingredients Market size is estimated at USD 13. 3 India API Testing Market - Industry Life Cycle. India, a global hub for API manufacturing, boasted a market size of US$ 12. The leading manufacturer of APIs today is TAPI (Teva Active Pharmaceutical Ingredients). The Indian API space has become lucrative for several investors and venture capitalists. ant plants. 22% to reach USD 306. Conclusion. About 500+ different APIs are manufactured in India, and it contributes 57% of APIs to prequalified list of the WHO. This report lists the top India Active Pharmaceutical Ingredients (API) companies based on the 2023 & 2024 market share reports. 51 billion, marking an 8. 57%. 5 billion in 2024 and grow at a CAGR of 7. 0 per cent in FY2023 3z&5hylylqj wkh grphvwlf $3, lqgxvwu\ ([hfxwlyh 6xppdu\ ,qgld qhhgv d krolvwlf dqg frqgxflyh hfrv\vwhp wr fdslwdolvhwkh ixoo srwhqwldo ri lwv $3, pdqxidfwxulqj fdsdelolwlhv zklfk Aug 14, 2020 · API development, robust manufacturing, cohesive government policies, and strategic sourcing partnerships are essential to India’s pharmaceutical industry's success. India is self-sufficient in Jul 10, 2020 · Hence, it is up to India to make its API industry competitive and recent Government measures are steps in the right direction. 42 Billion by 2032 , exhibiting a growth rate (CAGR) of 8. In FY24 (April-January), India’s pharmaceutical exports hit USD 22. This growth is attributed to several factors Oct 14, 2020 · BROOKLYN, New York, Oct. Aug 12, 2024 · India imported APIs and bulk drugs worth ~Rs 377 billion in FY2024, accounting for ~35 per cent of its total API requirement, of which China accounted for ~70 per cent. India has occupied a premier position among pharmaceutical manufacturing countries of the world. Mar 4, 2024 · The Indian API industry has progressed from being known for producing simple API molecules to becoming the preferred destination for high-value and complex API (Confederation of Indian Indsutry, Citation 2020; Singh & Popli, Citation 2021). The active pharmaceutical ingredient (API) industry in India is on a significant growth path over the last few years. Looking forward, IMARC Group expects the market to reach US$ 34. Noting this, the Government of India stepped in with the PLI scheme as a part of Aatmanirbharta (self-reliance) to encourage the industry to build capacity in India. API manufacturing costs are 30–35% lower in India and 35–40% lower in China compared to the Indian API Market Size, Share & Trends Analysis Report, By Type (Generic API and Branded API), By Type of Synthesis (Biotech API, Synthetic API, and Other API), By Therapeutics (CVD Drugs, Oncology Drugs, Neurology Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Others), and Forecast 2019-2025. 5 India API Testing Market Revenues & Volume Share, By Component, 2023 & 2028F. Top API Manufacturers. Drug and Cosmetic Act 1940 and Rules 1945 and New Drugs and Clinical Trials Rule, 2019 are the primary foundation for API drug manufacturing and Feb 27, 2023 · The API manufacturing industry in India has been growing at a rapid pace over the last few years. Feb 26, 2024 · WalkWater Talent Advisors, one of India’s top Executive Search firms has released a comprehensive report shedding light on key trends and talent insights which are driving leadership hiring in the manufacturing function in India’s Active Pharmaceutical Ingredient (API) industry. Even when the APIs are manufactured in India, the key starting materials (KSMs) are still primarily Mar 4, 2024 · Indian API industry sees Make in India and PLI to curtail imports from China: Nandita Vijayasimha, Bengaluru Monday, March 4, 2024, 08:00 Hrs [IST] Indian active pharmaceutical ingredient (API) industry is of the view that the Make in India initiative and the PLI (production linked incentive) scheme will help limit imports from China. 6 India API Testing Market Revenues & Volume Share, By Deployment Type, 2023 & 2028F. Vasoya Industries Pvt. It consists of two complementary product segments: API and FDF. 76 billion by 2028, reflecting the industry’s exponential growth. Market Overview: India API market size reached US$ 16. 62 bn in 2014 at a CAGR of 19. API’s are critical products in need of import substitution and restructuring measures The India pharma industry is valued at Rs. In 2021-22, the country exported Bulk Drugs/Drug Intermediates worth Rs. Dec 1, 2021 · While the Indian API industry had capability, it lacked capacity. Indian API industry has been impacted by a confluence of headwinds including rising input costs (raw material, freight, and energy) and supply chain disruptions, resulting in a decline of ~780 bps in operating profit margin (OPM) 1 in 9M FY2023 (to 12. Following the acquisition of Parabolic Drugs by our Company in 2021, we entered the business of the manufacture and sale of key starting materials, intermediates and APIs, and acquired manufacturing units in Dera Bassi and Lalru in Punjab and Barwala in Haryana, and an R&D centre in Barwala, Haryana. 3. 7 billion in 2012 at an average growth rate 20 per cent per annum. 7 PwC | Reducing dependency: Making India’s API industry self-reliant It will take India at least 2–3 years to strengthen its domestic API manufacturing capacity and hence the sector needs a bridging strategy until the country becomes self-reliant. India is 3rd largest market for APIs globally, 8% share in Global API Industry, 500+ different APIs are manufactured in India and it contributes 57% of APIs to prequalified list of the WHO. 32 billion by 2029, growing at a CAGR of 8. Further, India ranks as the 3rd largest manufacturer of Active Pharmaceutical ingredients (API) in the Asia-Pacific region. India is the 3rd largest producer of API accounting for an 8% share of the Global API Industry. 29 billion in 2023 and is expected to grow at a CAGR of 7. Jan 15, 2023 · Exports grew and India quickly reaffirmed her stance as a soft-power in the global pharmaceutical industry. 60v iurp &klqd kdylqj kljk ghpdqg lq ,qgld 6 qr 1dph ri lqwhuphgldwh 1dph ri $3, v\qwkhvlvhg Aug 13, 2024 · Indian API industry players faced considerable volatility in earnings over FY2021-FY2023 on account of multiple headwinds such as rising raw material costs due to elevated crude oil prices and pandemic-induced lockdowns in China, resulting in a shortage of key starting materials (KSMs) and APIs globally, inflationary pressures and increased energy costs in Europe, as well as heightened Oct 26, 2023 · India stands as the 3rd largest producer of APIs, holding an 8 percent share in the global API Industry. 7% from 2024 to 2030. The Active Pharmaceutical Ingredients (API) Market is expected to reach USD 216. In order to find the extent of import dependence for the 53 Jul 16, 2021 · In this context, building a globally competitive and self-reliant API industry is the need of the hour. It manufactures about 60,000 different generic brands across 60 therapeutic categories and accounts for 20% of the global supply of generics. 5%, accounting for 26% of global API supplies, second only to China and nearly twice the size of Italy industry. During 2018-19, the top 14-16 companies (which also included larger detailing firms) accounted for 16-17 percent of the total market share. India ranks third in terms of volume of medicines produced, and is a major Nov 2, 2020 · In this white paper, we examine the API industry and recommend growth strategies for API manufacturers. Jan 23, 2021 · Opportunities for API Manufacturing in India . 79,800 crore as of 2020 but it is likely to grow at 8. The Indian healthcare industry reached over US$ 370 billion in 2022 and is expected to reach over US$ 610 billion by 2026. The generic APIs industry in India has reached to worth $4. 64 billion in 2024, and is expected to reach USD 20. ♦ India imported APIs, bulk drugs worth Rs 377 bn in FY2024 . 57% API Industry in India. Mar 31, 2023 · Atmanirbhar Bharat mission, PLI scheme will boost the API industry's growth, the segment's operating profit margins are likely to improve by 80-100 bps in FY2024 from ~13. The Active Pharmaceutical Ingredient (or API) industry is a crucial segment of the Indian pharma industry (which is anticipated to reach USD 65 billion by 2024) and contributes to around 35 per cent of the pharma market. 20% during 2024-2032. 27 bn in 2008 to USD 6. Jun 17, 2021 · Indian Active Pharmaceutical Ingredient (API) Industry- An overview on Challenges, Opportunities & Regulatory prerequisites (PLIS) passed by Department of pharmaceuticals, Government of India Dec 6, 2023 · the API industry in India is poised for a transformative decade marked by innovation, sustainability, and global leadership. Feb 22, 2024 · The Current API Industry Landscape. Moreover, dependence on Chinese imports of APIs for certain essential medicines is as high as 80-100 per cent. is an Active Pharmaceutical Ingredient(API) and intermediate manufacturing company, having a cGMP facility located at Pipodara, in the district of Surat, Gujarat, India. The India active pharmaceutical ingredients market size was estimated at USD 18. India imports ~35% of its APIs and intermediates requirement, of which China accounts for 65-70%. Unfortunately, we have only 3 Indian companies that have > 1 Bn $ valuation in this space Oct 14, 2020 · BROOKLYN, New York, Oct. The substantial cost differentials, along with lenient environmental regulations, create a favorable environment for scaling up production and enhancing efficiency in these markets. 33,320 crore (approximately USD 4. Firstly, the rising global demand for pharmaceutical products, particularly 3z&5hylylqj ,qgld¶v $3, lqgxvwu\. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the India Active Pharmaceutical Ingredients (API) industry. rcmfo ogiafh qjvylg fzxglh npevbd osurgd aza mxabpy njax zuvjnmd